VIR FY 2024 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$74M-13.9% YoY

Gross Profit

-$404M-545.0% margin

Operating Income

-$587M-791.3% margin

Net Income

-$522M-703.4% margin

EPS (Diluted)

$-3.83

Cash Flow

Operating Cash Flow

-$446M

Free Cash Flow

-$454M

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$248M

Stockholders' Equity

$1.2B

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$86M	-13.9%
Gross Profit	-$404M	-$487M	+16.9%
Operating Income	-$587M	-$684M	+14.2%
Net Income	-$522M	-$615M	+15.1%